Logo

American Heart Association

  12
  0


Final ID: MP35

Community Prevalence of the Cardiovascular-Kidney-Metabolic (CKM) Syndrome: The Dallas Heart Study

Abstract Body: Introduction: The recent AHA presidential advisory on Cardiovascular-Kidney-Metabolic Syndrome (CKM) proposed a novel staging scheme, but limited data exist regarding CKM stage prevalence in the community. Prior population-based studies have lacked subclinical imaging measures, and have not reported variability by age, gender, and race/ethnicity.

Methods: We estimated the population prevalence of CKM stages in Dallas County, from among 2,817 participants in the population-sampled Dallas Heart Study who attended study Visit 1 (2000-2002). Participants underwent protocol measurement of body composition, lipids, fasting blood sugar, serum creatinine, NT-proBNP, hs-cTnT, urinary albumin and creatinine, coronary artery calcium by cardiac CT (CAC), and cardiac function and mass by cardiac MRI. These were used to operationalize the following CKM stages: 0 – no CKM risk factors; 1 – excess or dysfunctional adiposity (body mass index, waist circumference, and fasting blood glucose); 2 – metabolic risk factors (hypertriglyceridemia, hypertension, diabetes, metabolic syndrome) and chronic kidney disease; 3 – subclinical cardiovascular diseases (CAC, LV hypertrophy or dysfunction by cardiac MRI, elevated cardiac biomarkers (NT-proBNP or hs-cTnT), high AHA-PREVENT or KDIGO scores); 4 – prevalent cardiovascular diseases (coronary heart disease, heart failure, atrial fibrillation, stroke). We used sampling weights to estimate the prevalence of CKM stages in Dallas County in 2000-2002 overall and by age category (30-44, 45-59, 60-65 years), gender, and race/ethnicity.

Results: Among the 2,817 participants with a mean age of 44±10 years, the sample weighted demographics were 50% women, 52% non-Hispanic White, 20% non-Hispanic Black, and 26% Hispanic race/ethnicity. Among Dallas County adults, only 10% were CKM Stage 0 (no risk factors). The weighted prevalence of CKM Stages 1 through 4 was 16%, 46%, 23%, and 5%, respectively (Figure A). CKM stage prevalence was similar between men and women, while CKM Stage 4 was more frequent among older individuals and among non-Hispanic Black compared with non-Hispanic White and Hispanic individuals (Figure B).

Conclusion: The public health burden of CKM is substantial. Ninety percent of Dallas County residents in 2000-2002 had some form of CKM syndrome, nearly half demonstrated metabolic dysfunction (Stage 2), and nearly one-fourth had subclinical cardiovascular disease (Stage 3).
  • Shelbaya, Khaled  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • De Lemos, James  ( UT SOUTHWESTERN MEDICAL CTR , Dallas , Texas , United States )
  • Shah, Amil  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Zeleke, Yinun  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Lamberson, Victoria  ( UT Southwestern Medical Center , Yorktown , Virginia , United States )
  • Yang, Yimin  ( Brigham and Women's Hospital , Woodland , California , United States )
  • Ayers, Colby  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Neeland, Ian  ( University Hospitals - Case Western , Cleveland , Ohio , United States )
  • Rohatgi, Anand  ( UT SOUTHWESTERN , Dallas , Texas , United States )
  • Joshi, Parag  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Khera, Amit  ( UT Southwestern , Dallas , Texas , United States )
  • Author Disclosures:
    Khaled Shelbaya: DO have relevant financial relationships ; Researcher:Alexion:Expected (by end of conference) | James de Lemos: No Answer | Amil Shah: DO NOT have relevant financial relationships | Yinun Zeleke: No Answer | Victoria Lamberson: DO NOT have relevant financial relationships | Yimin Yang: DO NOT have relevant financial relationships | Colby Ayers: DO have relevant financial relationships ; Consultant:NIH:Active (exists now) | Ian Neeland: No Answer | Anand Rohatgi: No Answer | Parag Joshi: No Answer | Amit Khera: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

MP06. Cardiometabolic Health and Disorders

Friday, 03/07/2025 , 05:00PM - 07:00PM

Moderated Poster Session

More abstracts on this topic:
Cardiac Catheterization in Kidney Transplant Patients Presenting with Non-ST Segment Elevation Myocardial Infarction: A Five-year Nationwide Analysis

Al Akeel Mohannad, Eldawud Daoud, Jha Mayank, Harikrishna Arya, Jain Hritvik, Abdulfattah Ammar, Alamro Yazan, Patel Jeetendra

Hyperkalemia-Related Hospitalization Associated with Short-Term vs. Long-Term Outpatient SZC Therapy Among RAASi Users: The GALVANIZE Outcome study

Colman Ellen, Rhee Connie, Agiro Abiy, Mu Fan, Cook Erin, Greatsinger Alexandra, Smith Jess, Reichert Emily, Malhotra Arun, Kumar Neela

More abstracts from these authors:
Metabolomic Markers of Aortic Stenosis Development: the Atherosclerosis Risk in Communities (ARIC) Study

Shelbaya Khaled, Lamberson Victoria, Yang Yimin, Zhou Peidi, Alkis Taryn, Matsushita Kuni, Yu Bing, Shah Amil

Need for Testing Standardization and Improved Treatment of Elevated Lipoprotein(a) at a Large Urban Academic Medical Center

Wong Willis, Kao Cindy Hsin-yi, Schneider Ruth, Navar Ann Marie, Rohatgi Anand, Khera Amit, Joshi Parag

You have to be authorized to contact abstract author. Please, Login
Not Available